07 Jan 2021 --- Aker BioMarine has obtained exclusive rights to the University of Illinois Chicago’s (UIC) intellectual property related to lysophosphatidylcholine (LPC), being researched for its function on brain and eye health. The licensing agreement allows Aker BioMarine to materialize the current research results at UIC.
